BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 7 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2022. The put-call ratio across all filers is 3.11 and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $605,000 | +3.8% | 4,000 | 0.0% | 0.26% | +13.3% |
Q2 2022 | $583,000 | +23.0% | 4,000 | 0.0% | 0.23% | +49.4% |
Q1 2022 | $474,000 | -14.0% | 4,000 | 0.0% | 0.16% | -7.1% |
Q4 2021 | $551,000 | -0.9% | 4,000 | 0.0% | 0.17% | -8.2% |
Q3 2021 | $556,000 | +43.3% | 4,000 | 0.0% | 0.18% | +45.2% |
Q2 2021 | $388,000 | +42.1% | 4,000 | 0.0% | 0.13% | +32.6% |
Q1 2021 | $273,000 | -20.4% | 4,000 | 0.0% | 0.10% | -25.2% |
Q4 2020 | $343,000 | +31.9% | 4,000 | 0.0% | 0.13% | +16.5% |
Q3 2020 | $260,000 | -11.0% | 4,000 | 0.0% | 0.11% | -18.0% |
Q2 2020 | $292,000 | +33.9% | 4,000 | 0.0% | 0.13% | +47.8% |
Q4 2019 | $218,000 | – | 4,000 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |